跳至主要内容
临床试验/NL-OMON38540
NL-OMON38540已完成2 期

Plaque stabilization and restoration of vascular function by bioresorbable vascular scaffold in acute coronary syndrome prone patients - ABSORB-PREVENT

Canisius Wilhelmina Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Symptomatic patients between the age of 18 and 80 years
  • - Morise Risk score of *9 (intermediate or high risk) but no proven ischemia (no positive troponin or ST-elevation)
  • - Intermediate coronary lesion on CT scan (50-70% based on CT estimate) and a plaque with at least two of the following vulnerability criteria: Napkin ring sign, positive remodeling, low attenuation and spotty calcification
  • - FFR negative lesion at coronary angiogram
  • - Vessel diameter *2.5 mm on visual estimate

排除标准

  • - High calcium score on CT scan preventing adequate evaluation of the coronary lesion.
  • - Lesions located in a coronary vessels previously stented.
  • - Left main (>50%) or known three vessel disease.
  • - Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparine or Everolimus and known true anaphylaxis to prior contrast media or known bleeding diathesis or known coagulopathy.

研究者

发起方
Canisius Wilhelmina Ziekenhuis

相似试验

Plaque stabilization and restoration of vascular... | 临床试验